R&D
The long-delayed promise of the microbiome, with Sam Possemi...
Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Oncology
A cancer treatment modality that prioritises QoL, with Ben Z...
Immuneering's Ben Zeskind explains how, by focusing on quality of life as well as quantity, they've created a drug for pancreatic cancer.
R&D
Allogeneic cell therapy isn’t dead, with Brian Culley
Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.
Oncology
Engineering “smarter” cells, with Tim Lu
Senti Bio's Tim Lu discusses “logic-gated” cells, which have multiple receptors allowing them to attack cancer cells while leaving healthy cells alone
R&D
DNA as a programmable language, with Adrian Woolfson and Kai...
A new technology just announced this weekend in a paper in Nature could have a radical impact on how gene assembly is carried out.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
